3569 results for «250»

Filter By

3569 results

PCI optimisation: OCT and physiology in a complex multivessel disease case

18 Dec 2019 – From GulfPCR-GIM 2019

The patient is a 57-year-old male with high-risk factors and previous history of revascularisation. He presents with ischemic chest pain with NSTE-ACS. The baseline angiography shows multivessel disease and calcified LAD/D1 bifurcation (1,1,0).

The key objectives of this case are:

  1. Utility of FFR in physiological assessment of a...
PCI optimisation: OCT and physiology in a complex multivessel disease case

Updates in TAVI therapies

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session to learn more about the latest updates in TAVI therapies, and discover the unique features of Acurate neo and Lotus Edge, the clinical evidence of both Boston Scientific TAVI platforms, while learning all about the needs of cerebral protection during TAVI procedures.

Updates in TAVI therapies

All you need to know to start optimising outcomes in PCI: OCT and physiology

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this session on the new developments and future directions in functional coronary assessment to discover how and why physiology assessment/OCT could optimise procedural outcomes in PCI, and learn all about their main indications, the relevant indicators to be assessed, as well as the last changes...

All you need to know to start optimising outcomes in PCI: OCT and physiology

Shaping the future of transcatheter valve interventions

19 Dec 2019 – From GulfPCR-GIM 2019

Consult this sesson to discover the future perspectives and innovations on transcatheter valve interventions, and learn of a new therapy in high surgical risk patients with the Tendyne clinical programme, which eliminates mitral regurgitation.

Shaping the future of transcatheter valve interventions

Improving patient access and clinical outcomes for valvular heart disease

18 Dec 2019 – From GulfPCR-GIM 2019

Consult this session on valvular heart disease to learn more about the indication expansion for aortic stenosis patients and the implication of valve design choice for the patient's future, and discover some new treatment options for mitral valve disease.

Improving patient access and clinical outcomes for valvular heart disease

Complex TAVI procedures: valve-in-valve

17 Nov 2019 – From PCR London Valves 2019

Consult this session to discover how to manage complex valve-in-valve TAVR, with a selection of clinical cases regarding severe aortic regurgitation in a degenerated aortic homograft, pure regurgitation into an invisible Bentall conduit, and more!

Complex TAVI procedures: valve-in-valve

Aortic anatomy and pathophysiology LIVE – An in-depth interactive workshop

17 Nov 2019 – From PCR London Valves 2019

Mitral anatomy and pathophysiology LIVE – An in-depth interactive workshop

17 Nov 2019 – From PCR London Valves 2019

Special procedures: transcaval access

17 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about the management of transcaval access and closure for your TAVI patients, and discover various solutions and devices to cope with most complications and plan ahead for all eventualities.

Special procedures: transcaval access

Special procedures: the BASILICA to avoid coronary obstruction in high risk anatomy

17 Nov 2019 – From PCR London Valves 2019

Consult this session to discover various approaches to predict coronary obstruction in high risk anatomy and gain insight into BASILICA, an emerging technique to avoid this major complication, thanks to a selection of challenging clinical cases.

Special procedures: the BASILICA to avoid coronary obstruction in high risk anatomy

Tricuspid anatomy and pathophysiology LIVE – An in-depth interactive workshop

17 Nov 2019 – From PCR London Valves 2019

Imaging essentials in mitral regurgitation

17 Nov 2019 – From PCR London Valves 2019

Consult this session focusing on imaging in mitral regurgitation to gain insight into the importance of echocardiography in transcatheter mitral procedures to assess mitral valve morphology, regurgitation severity and risks for complications and to guide access, device positioning and post-deployment hemodynamics.

Imaging essentials in mitral regurgitation

Introduction to the PCR London Valves 2019 Mitral and Tricuspid track - The key questions in mitral and tricuspid valve interventions: where are we in 2019?

18 Nov 2019 – From PCR London Valves 2019

Consult this session to appreciate the critical importance of the Heart Team in identifying the optimal treatment strategy for patients with mitral and tricuspid valve disease, and to learn more about the challenges of transcatheter mitral and tricuspid valve interventions and the complexities associated with patient and device...

Introduction to the PCR London Valves 2019 Mitral and Tricuspid track - The key questions in mitral and tricuspid valve interventions: where are we in 2019?

Mitral regurgitation: a comprehensive patient-based approach

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about the pathophysiology of mitral regurgitation, and discover its implications for device design, selection and durability, which imaging modality is the most relevant to clinical decision-making, and how Heart Team working can provide the best treatment option for complex patients.

Mitral regurgitation: a comprehensive patient-based approach

Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet

19 Nov 2019 – From PCR London Valves 2019

Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!

Controversy - Challenges

Will PARTNER-3 and Evolut low-risk trials change my practice?

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.

Will PARTNER-3 and Evolut low-risk trials change my practice?

TAVI: management of unusual complications

19 Nov 2019 – From PCR London Valves 2019

Consult this session to learn more about how to manage the following unusual TAVI complications: wire entrapment in hypertrabecular left ventricle after aortic valve release, iatrogenic VSD after TAVI in a patient with bicuspid severe aortic stenosis, ruptured pseudoaneurysm of the mitral-aortic intervalvular fibrosa, unsuccessful TAVI in...

TAVI: management of unusual complications

Innovations in transcatheter tricuspid valve intervention

18 Nov 2019 – From PCR London Valves 2019

Consult this session to learn all about the innovations in transcatheter tricuspid valve intervention: discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.

Innovations in transcatheter tricuspid valve intervention

Transcatheter edge-to-edge repair for secondary mitral regurgitation - Session with LIVE case

19 Nov 2019 – From PCR London Valves 2019

Watch this session with a LIVE demonstration from Clinique Pasteur - Toulouse, France

Transcatheter edge-to-edge

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions

18 Nov 2019 – From PCR London Valves 2019

Consult this session on patient selection for tricuspid valve interventions to gain insights into how clinical and anatomical characteristics influence patient and device selection, and to become more familiar with the key steps in transcatheter tricuspid valve procedures.

Case-based learning for the Heart Team: patient selection for tricuspid valve interventions
Didn’t find what you were looking for?